Argenx
ARGX
#527
Rank
HK$299.07 B
Marketcap
HK$4,986
Share price
-2.92%
Change (1 day)
68.49%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: HK$299.07 Billion

As of January 2025 Argenx has a market cap of HK$299.07 Billion. This makes Argenx the world's 527th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$299.07 B2.86%
2024HK$290.75 B64.97%
2023HK$176.24 B7.63%
2022HK$163.75 B14.19%
2021HK$143.39 B31.92%
2020HK$108.69 B102.91%
2019HK$53.57 B95.11%
2018HK$27.45 B75.28%
2017HK$15.66 B
2014HK$1.12 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Argenx was reported to be:

HK$309.77 Billion
by Yahoo Finance info icon info icon
HK$309.77 Billion
by CompaniesMarketCap info icon info icon
HK$304.04 Billion
by Nasdaq info icon info icon